Furthermore, the study of RAAS inhibition by an Ang II receptor blocker, Valsaratan, in CRC mouse models demonstrated CRC cell growth suppression and inhibition of cell migration by perturbation of MMP-2 and MMP-9 [256]. This evidence concerns the gene MMP9 and colorectal carcinoma.